Ascend, Xellia Announce Refunds for 340B Overcharges

Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations.
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Organon To Extend Contract Pharmacy Restrictions to CHCs on Dec. 1

Organon announced that, effective Dec. 1, it will extend its contract pharmacy restrictions to HRSA-funded health centers.
A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

The Health Equity Collaborative called for 340B program overhauls in a new white paper.
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’

Joe Grogan (left), a top official in the former Trump administration raised serious concerns with the 340B program during the keynote address at The Association for Value-Based Cancer Care Annual Summit in New York Thursday.
A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended

J&J's proposed rebate model was a key topic of discussion at a Wednesday panel led by moderator, 340B Report Publisher and CEO Ted Slafsky.
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Leader Slams J&J Rebate Proposal, Urges Providers to ‘Remain Vigilant’ in Op-Ed

Maureen Testoni, the president and CEO of 340B Health celebrated J&J’s retreat from a 340B rebate proposal in an Oct. 9 RACmonitor op-ed.
The head of an influential 340B hospital advocacy group claimed “victory” in the recent fight against Johnson & Johnson’s (J&J) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

Sally Pipes, the president and CEO of the drug-industry funded Pacific Research Institute, criticized pushback that led Johnson & Johnson to forgo its plans to implement a 340B rebate model in an Oct. 7 Forbes op-ed.
The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Praise Federal Court’s Defense of Louisiana Contract Pharmacy Law as Drug Industry Weighs Next Steps

A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.
A key federal court decision to uphold Louisiana’s contact pharmacy law this week is drawing praise from provider groups and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live